Prokidney (PROK) Market Capitalization (2021 - 2026)
Prokidney's (PROK) quarterly Market Capitalization came in at $1.0 billion in Q2 2026, up 313.3% year-over-year from $252.3 million in Q2 2025, and up 31.24% quarter-over-quarter from $794.6 million in Q1 2026.
Analysis
Prokidney (PROK) Market Capitalization (2021 - 2026) Analysis & Trends
Prokidney (PROK) has reported Market Capitalization for 6 consecutive years, with $1.0 billion the latest figure, recorded in Q2 2026.
- On a quarterly basis, Market Capitalization rose 313.3% year-over-year to $1.0 billion in Q2 2026; TTM through Jun 2026 was $1.0 billion, a 313.3% increase from a year earlier, with the FY2025 full-year figure at $992.0 million, up 39.83% from the prior year.
- Market Capitalization was $1.0 billion for Q2 2026 at Prokidney, up from $794.6 million in the prior quarter.
- Over five years, Market Capitalization peaked at $3.4 billion in Q1 2023 and troughed at $252.3 million in Q2 2025.
- A 5-year average of $1.2 billion and a median of $898.9 million in 2024 frame the typical range for Market Capitalization.
- Across the five-year window, Market Capitalization jumped 1222.38% in 2023 and tumbled 85.78% in 2024, its largest moves.
- Over 5 years, Market Capitalization stood at $2.0 billion in 2022, then sank by 74.63% to $512.7 million in 2023, then surged by 38.37% to $709.5 million in 2024, then soared by 39.83% to $992.0 million in 2025, then climbed by 5.13% to $1.0 billion in 2026.
- The last three Market Capitalization figures came in at $1.0 billion (Q2 2026), $794.6 million (Q1 2026), and $992.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Prokidney | 346.07 Mn | 346.07 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.04 Bn |
| Mar 31, 2026 | 794.64 Mn |
| Dec 31, 2025 | 992.05 Mn |
| Sep 30, 2025 | 1.06 Bn |
| Jun 30, 2025 | 252.34 Mn |
| Mar 31, 2025 | 371.57 Mn |
| Dec 31, 2024 | 709.47 Mn |
| Sep 30, 2024 | 805.69 Mn |
| Jun 30, 2024 | 1.02 Bn |
| Mar 31, 2024 | 477.18 Mn |
| Dec 31, 2023 | 512.74 Mn |
| Sep 30, 2023 | 1.36 Bn |
| Jun 30, 2023 | 3.32 Bn |
| Mar 31, 2023 | 3.36 Bn |
| Dec 31, 2022 | 2.02 Bn |
| Sep 30, 2022 | 2.65 Bn |
| Jun 30, 2022 | 255.12 Mn |
| Mar 31, 2022 | 253.84 Mn |
| Dec 31, 2021 | 207.45 Mn |
| Sep 30, 2021 | 248.51 Mn |